Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia.
about
Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumoniaImpact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory studyLocal activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumoniaFeasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia.Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance.The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia.4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumoniaNeither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injuryPlasminogen activator inhibitor-1 does not contribute to the pulmonary pathology induced by acute exposure to ozone.Streptococcus pneumoniae serine protease HtrA, but not SFP or PrtA, is a major virulence factor in pneumonia.Intracellular and extracellular serpins modulate lung disease.Prevalence and significance of coagulation abnormalities in community-acquired pneumonia.Effects of specific chemical suppressors of plasminogen activator inhibitor-1 in cardiovascular diseases.Proteolysis of plasminogen activator inhibitor-1 by Yersinia pestis remodulates the host environment to promote virulenceRelative Tissue Factor Deficiency Attenuates Ventilator-Induced Coagulopathy but Does Not Protect against Ventilator-Induced Lung Injury in Mice.PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in miceProtease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study.Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung InjuryRole played by Toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation.CD44 is protective during hyperoxia-induced lung injury.Transgenic tissue-type plasminogen activator expression improves host defense during Klebsiella pneumonia.Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia.Systemic inhibition and liver-specific over-expression of PAI-1 failed to improve survival in all-inclusive populations or homogenous cohorts of CLP mice
P2860
Q33919261-0D5FC116-2EF8-428F-A099-B2558ECD5A72Q34022566-6976A6CB-56CF-4BEF-8353-846AE7E81F2BQ34153324-5A385CA9-8C06-4D22-90D1-F3CB60E4ACA1Q35536493-0DCE12CF-8BA6-46BD-96AA-F2E5752F356FQ35636201-AD90F542-B4A9-4CB2-B965-2152A89F6CC5Q35688843-E7DEF0DE-4168-4876-8C56-2D98B6C7D4F1Q35825316-AA5A6BA0-DD6A-42F9-B97F-4EA63FFC5449Q36330600-7EBDE646-84BE-4A92-B6FC-BC06A7215E19Q37138889-87BE1F11-EB1C-437B-8C6E-E66B4AD510A2Q37286847-E2C45942-0CE8-4B09-9640-28250EDEE75BQ37297500-17AEF6EE-9CFD-4D6B-93A2-74DCFD11DD79Q37341652-7879B5DB-CCB1-4C60-8D6D-ACB0EF3011B0Q37344928-C5412700-09D6-4641-A785-267B4376154BQ37824876-B5AE2D82-5B8D-4E9B-9D75-28D706711D72Q39633118-44A4C7A3-6158-4C1B-872B-DA3F575A4374Q39802234-C15E3261-720A-4977-BC2F-45F1D3FB35EFQ41261629-AAB06DE8-C3B9-4722-8B6A-D1ECDEF5F386Q41459860-C7618286-BF33-4612-A038-3F887A832391Q41525556-2B43533D-1CAC-48BA-8806-84A934501699Q42137123-936690CD-B3BC-45EE-8329-29BFFB10FF55Q43491698-E058C1DF-FF5D-422D-927C-29F222E90D26Q44540829-BE5B3564-7F10-4A97-AE9B-8E9C40117631Q51719546-47F3C463-563F-4807-B0A4-CBED14E1F5A8Q55123953-1E84EBDC-2C8B-4A2B-9514-732637731582Q58106436-EDBE0E6A-CA9E-4A69-9BCA-9A67BBA803DE
P2860
Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Plasminogen activator inhibito ...... murine pneumococcal pneumonia.
@en
Plasminogen activator inhibito ...... murine pneumococcal pneumonia.
@nl
type
label
Plasminogen activator inhibito ...... murine pneumococcal pneumonia.
@en
Plasminogen activator inhibito ...... murine pneumococcal pneumonia.
@nl
prefLabel
Plasminogen activator inhibito ...... murine pneumococcal pneumonia.
@en
Plasminogen activator inhibito ...... murine pneumococcal pneumonia.
@nl
P2093
P1433
P1476
Plasminogen activator inhibito ...... murine pneumococcal pneumonia.
@en
P2093
Anita W Rijneveld
Jaring S Van Der Zee
Marcel Levi
Paul Bresser
Peter Speelman
Roger Lijnen
Tom Van Der Poll
Vivian De Waard
P304
P356
10.1182/BLOOD-2003-01-0227
P407
P577
2003-04-17T00:00:00Z